{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T13:02:56Z","timestamp":1793106176861,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2002,6,25]],"date-time":"2002-06-25T00:00:00Z","timestamp":1024963200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2002,7]]},"DOI":"10.1038\/sj.bjc.6600344","type":"journal-article","created":{"date-parts":[[2002,9,3]],"date-time":"2002-09-03T17:30:36Z","timestamp":1031074236000},"page":"15-20","source":"Crossref","is-referenced-by-count":70,"title":["A phase I dose-escalating study of DaunoXome, liposomal daunorubicin, in metastatic breast cancer"],"prefix":"10.1038","volume":"87","author":[{"given":"K J","family":"O'Byrne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A L","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R A","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"DeCatris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Shields","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Beare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W P","family":"Steward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2002,6,25]]},"reference":[{"key":"BF6600344_CR1","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/bjc.1993.146","volume":"67","author":"R A'hern","year":"1993","unstructured":"A'hern R, Smith I, Ebbs S (1993) Chemotherapy and survival in advanced breast cancer: the inclusion of doxorubicin in Cooper type regimens. Br J Cancer 67: 801\u2013805","journal-title":"Br J Cancer"},{"key":"BF6600344_CR2","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1200\/JCO.2001.19.5.1444","volume":"19","author":"G Batist","year":"2001","unstructured":"Batist G, Ramakrishnan G, Sekhar Rao C, Chandrasekharan A, Gutheil J, Guthrie T, Shah P, Khojasteh A, Krishnan Nair M, Hoelzer K, Tkaczuk K, Choi Park Y, Lee LW (2001) Reduced cardiotoxicity and preserved anti-tumour efficacy of liposome-encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in a randomised, multicenter trial of metastatic breast cancer. J Clin Oncol 19: 1444\u20131454","journal-title":"J Clin Oncol"},{"key":"BF6600344_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s002800000206","volume":"47","author":"R Bellott","year":"2001","unstructured":"Bellott R, Auvrignon A, Leblanc T, Perel Y, Gandemer V, Bertrand Y, Mechinaud F, Bellenger P, Vernois J, Leverger G, Baruchel A, Robert J (2001) Pharmacokinetics of liposomal daunorubicin (DaunoXome) during a phase I-II study in children with relapsed acute lymphoblastic leukaemia. Cancer Chemother Pharmacol 47: 15\u201321","journal-title":"Cancer Chemother Pharmacol"},{"key":"BF6600344_CR4","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/0277-5379(86)90149-5","volume":"22","author":"V Bonfante","year":"1986","unstructured":"Bonfante V, Ferrari L, Brambilla C, Rossi A, Villani F, Crippa F, Valagussa P, Bonadonna G (1986) New anthracycline analogs in advanced breast cancer. Eur J Cancer Clin Oncol 22: 1379\u20131385","journal-title":"Eur J Cancer Clin Oncol"},{"key":"BF6600344_CR5","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/bjc.1989.234","volume":"60","author":"MH Bronchud","year":"1989","unstructured":"Bronchud MH, Howell A, Crowther D, Hopwood P, Souza L, Dexter TM (1989) The use of granulocyte colony stimulating factor to increase intensity of treatment with doxorubicin in patients with breast and ovarian cancer. Br J Cancer 60: 121\u2013125","journal-title":"Br J Cancer"},{"key":"BF6600344_CR6","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1023\/A:1008323200102","volume":"10","author":"HJ Burstein","year":"1999","unstructured":"Burstein HJ, Ramirez MJ, Petros WP, Clarke KD, Warmuth MA, Marcom PK, Matulonis UA, Parker LM, Harris LN, Winer EP (1999) Phase I study of Doxil and vinorelbine in metastatic breast cancer. Ann Oncol 10: 1113\u20131116","journal-title":"Ann Oncol"},{"key":"BF6600344_CR7","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1002\/1097-0142(19850615)55:12<2761::AID-CNCR2820551206>3.0.CO;2-P","volume":"55","author":"A Buzdar","year":"1985","unstructured":"Buzdar A, Marcus C, Smith T (1985) Early and delayed clinical cardiotoxicity of doxorubicin. Cancer 55: 2761\u20132765","journal-title":"Cancer"},{"key":"BF6600344_CR8","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1200\/JCO.1999.17.8.2341","volume":"17","author":"S Chan","year":"1999","unstructured":"Chan S, Friedrichs K, Noel D, Pinter T, Van Belle S, Vorobiof D, Duarte R, Gil Gil M, Bodrogi I, Murray E, Yelle L, von Minckwitz G, Korec S, Simmonds P, Buzzi F, Gonzalez Mancha R, Richardson G, Warpole E, Ronzoni M, Murawsky M, Alakl M, Riva A (1999) Prospective randomized trial of docetaxel versus doxorubicin in patients with metastatic breast cancer. J Clin Oncol 17: 2341\u20132354","journal-title":"J Clin Oncol"},{"key":"BF6600344_CR9","first-page":"440","volume":"45","author":"EI Darskaia","year":"1999","unstructured":"Darskaia EI, Zubarovskaia LS, Afanas'ev BV (1999) Administration of liposomal preparation of DaunoXome for breast cancer in patients with poor prognosis. Vopr Onkol 45: 440\u2013444","journal-title":"Vopr Onkol"},{"key":"BF6600344_CR10","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1023\/A:1008361914894","volume":"11","author":"IW Flinn","year":"2000","unstructured":"Flinn IW, Goodman SN, Post L, Jamison J, Miller CB, Gore S, Diehl L, Willis C, Ambinder RF, Byr JC (2000) A dose-finding study of liposomal daunorubicin with CVP (COP-X) in advanced NHL. Ann Oncol 11: 691\u2013695","journal-title":"Ann Oncol"},{"key":"BF6600344_CR11","first-page":"3255","volume":"52","author":"EA Forssen","year":"1992","unstructured":"Forssen EA, Coulter DM, Proffitt RT (1992) Selective in vivo Localisation of Daunorubicin Small Unilamellar Vesicles in Solid Tumors. Cancer Res 52: 3255\u20133261","journal-title":"Cancer Res"},{"key":"BF6600344_CR12","doi-asserted-by":"publisher","first-page":"481","DOI":"10.3109\/08982109409037058","volume":"4","author":"EA Forssen","year":"1994","unstructured":"Forssen EA, Ross ME (1994) DaunoXome treatment of solid tumors: Preclinical and clinical investigations. J Liposome Res 4: 481\u2013512","journal-title":"J Liposome Res"},{"key":"BF6600344_CR13","first-page":"2066","volume":"56","author":"EA Forssen","year":"1996","unstructured":"Forssen EA, Mal\u00e9Brune R, Adler-Moore JP, Lee MJ, Schmidt PG, Krasieva TB, Shimizu S, Tromberg BJ (1996) Fluoresence imaging studies for the disposition of daunorubicin liposomes (DaunoXome) within tumor tissue. Cancer Res 56: 2066\u20132075","journal-title":"Cancer Res"},{"key":"BF6600344_CR14","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/S0959-8049(97)10156-3","volume":"34","author":"SD Fossa","year":"1998","unstructured":"Fossa SD, Aass N, Paro G (1998) A phase II study of DaunoXome in advanced urothelial transitional cell carcinoma. Eur J Cancer 34: 1131\u20131132","journal-title":"Eur J Cancer"},{"key":"BF6600344_CR15","first-page":"891","volume":"52","author":"AA Gabizon","year":"1992","unstructured":"Gabizon AA (1992) Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes. Cancer Res 52: 891\u2013896","journal-title":"Cancer Res"},{"key":"BF6600344_CR16","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1200\/JCO.1995.13.4.996","volume":"13","author":"PA Gill","year":"1995","unstructured":"Gill PA, Espina BM, Muggia F, Cabriales S, Tulpule A, Esplin JA, Liebman HA, Forssen E, Ross ME, Levine AM (1995) Phase I\/II clinical and pharmacokinetic evaluation of liposomal daunorubicin. J Clin Oncol 13: 996\u20131003","journal-title":"J Clin Oncol"},{"key":"BF6600344_CR17","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1200\/JCO.1996.14.8.2353","volume":"14","author":"PS Gill","year":"1996","unstructured":"Gill PS, Wernz J, Scadden DT, Cohen P, Mukwaya GM, von Roenn JH, Jacobs M, Kempin S, Silverberg I, Gonzales G, Rarick MU, Myers AM, Shepherd F, Sawka C, Pike MC, Ross ME (1996) Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin and vincristine in AIDS-related Kaposi's sarcoma. J Clin Oncol 14: 2353\u20132364","journal-title":"J Clin Oncol"},{"key":"BF6600344_CR18","doi-asserted-by":"publisher","first-page":"3312","DOI":"10.1200\/JCO.2001.19.14.3312","volume":"19","author":"AN Gordon","year":"2001","unstructured":"Gordon AN, Fleagle JT, Guthrie D, Parkin DE, Gore ME, Lacave AJ (2001) Recurrent epithelial ovarian carcinoma: a randomized phase III study of pegylated liposomal doxorubicin versus topotecan. J Clin Oncol 19: 3312\u20133322","journal-title":"J Clin Oncol"},{"key":"BF6600344_CR19","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/BF00874439","volume":"12","author":"P Guaglianone","year":"1994","unstructured":"Guaglianone P, Chan K, DelaFlor-Weiss E, Hanisch R, Jeffers S, Sharma D, Muggia F (1994) Phase I and pharmacologic study of liposomal daunorubicin (DaunoXome). Invest New Drugs 12: 103\u2013110","journal-title":"Invest New Drugs"},{"issue":"Suppl 3","key":"BF6600344_CR20","first-page":"33","volume":"11","author":"J Harvey","year":"1984","unstructured":"Harvey J, Goodman A, McFadden M, Schein P, Smith F (1984) A phase I study of daunorubicin in advanced untreatable malignancies. Sem Oncol 11: Suppl 3 33\u201335","journal-title":"Sem Oncol"},{"key":"BF6600344_CR21","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1200\/JCO.1989.7.5.560","volume":"7","author":"IC Henderson","year":"1989","unstructured":"Henderson IC, Allegra JC, Woodcock T, Wolff S, Bryan S, Cartwright K, Dukart G, Henry D (1989) Randomized clinical trial comparing mitoxantrone with doxorubicin in previously treated patients with metastatic breast cancer. J Clin Oncol 7: 560\u2013571","journal-title":"J Clin Oncol"},{"key":"BF6600344_CR22","first-page":"425","volume":"10","author":"Hupperets","year":"1996","unstructured":"Hupperets et al (1996) DaunoXome shows promise as breast cancer treatment. Oncology (Huntingt) 10: 425","journal-title":"Oncology (Huntingt)"},{"key":"BF6600344_CR23","first-page":"5","volume":"392","author":"R Langer","year":"1998","unstructured":"Langer R (1998) Drug delivery and targeting. Nature 392: 5\u201310","journal-title":"Nature"},{"key":"BF6600344_CR24","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0305-7372(76)80018-7","volume":"3","author":"L Lenaz","year":"1976","unstructured":"Lenaz L, Page JA (1976) Cardiotoxicity of adriamycin and related anthracyclines. Cancer Treat Rev 3: 111\u2013120","journal-title":"Cancer Treat Rev"},{"key":"BF6600344_CR25","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1002\/1097-0142(19891215)64:12<2431::AID-CNCR2820641206>3.0.CO;2-1","volume":"64","author":"M Lopez","year":"1989","unstructured":"Lopez M, Contegiacomo A, Vici P, Dello Ioio C, Di Lauro L, Pagliarulo C, Carpano S, Giannarelli D, De Placido S, Fazio S, Bianco AF (1989) A prospective randomized trial of doxorubicin versus idarubicin in the treatment of advanced breast cancer. Cancer 64: 2431\u20132436","journal-title":"Cancer"},{"key":"BF6600344_CR26","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1200\/JCO.2000.18.12.2385","volume":"18","author":"B Norris","year":"2000","unstructured":"Norris B, Prichard KI, James K, Myles J, Bennett K, Marlin S, Skillings J, Findlay B, Vandenberg T, Goss P, Latreille J, Rudinskas L, Lofters W, Trudeau M, Osoba D, Rodgers A (2000) Phase III comparative study of vinorelbine combined with doxorubicin alone in disseminated metastatic\/recurrent breast cancer: national cancer institute of canada clinical trials group study MA8. J Clin Oncol 18: 2385\u20132394","journal-title":"J Clin Oncol"},{"issue":"Suppl 3","key":"BF6600344_CR27","first-page":"36","volume":"11","author":"A Rahman","year":"1984","unstructured":"Rahman A, Goodman A, Foo W, Harvey J, Smith FP, Schein PS (1984a) Clinical pharmacology of daunorubicin in phase I patients with solid tumors: development of an analytical methodology for daunorubicin and its metabolites. Sem Oncol 11: Suppl 3 36\u201344","journal-title":"Sem Oncol"},{"issue":"Suppl 3","key":"BF6600344_CR28","first-page":"45","volume":"11","author":"A Rahman","year":"1984","unstructured":"Rahman A, Furnagalli A, Goodman A, Schein PS (1984b) Potential of liposomes to ameliorate anthracycline-induced cardiotoxicity. Sem Oncol 11: Suppl 3 45\u201355","journal-title":"Sem Oncol"},{"key":"BF6600344_CR29","doi-asserted-by":"publisher","first-page":"3185","DOI":"10.1200\/JCO.1997.15.10.3185","volume":"15","author":"MR Ranson","year":"1997","unstructured":"Ranson MR, Carmichael J, O'Byrne K, Stewart S, Smith D, Howell A (1997) Treatment of Advanced Breast Cancer With Sterically Stabilized Liposomal Doxorubicin: Results of a Multicenter Phase II Trial. J Clin Oncol 15: 3185\u20133191","journal-title":"J Clin Oncol"},{"key":"BF6600344_CR30","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1023\/A:1005879219554","volume":"15","author":"DS Richardson","year":"1997","unstructured":"Richardson DS, Kelsey SM, Johnson SA, Tighe M, Cavenagh JD, Newland AC (1997) Early evaluation of liposomal daunorubicin (DaunoXome, Nexstar) in the treatment of relapsed and refractory lymphoma. Invest New Drugs 15: 247\u2013253","journal-title":"Invest New Drugs"},{"key":"BF6600344_CR31","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1200\/JCO.2001.19.6.1716","volume":"19","author":"E Rivera","year":"2001","unstructured":"Rivera E, Valero V, Syrewicz L, Rahman Z, Esteva FL, Theriault RL, Rosales MM, Booser D, Murray JL, Bast Jr RC, Hortobagyi GN (2001) Phase I study of stealth liposomal doxorubicin in combination with gemcitabine in the treatment of patients with metastatic breast cancer. J Clin Oncol 19: 1716\u20131722","journal-title":"J Clin Oncol"},{"key":"BF6600344_CR32","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1200\/JCO.1984.2.4.275","volume":"2","author":"M Rozencweig","year":"1984","unstructured":"Rozencweig M, ten Bokkel Huinink W, Cavelli F, Bruntsch U, Dombernowsky P, Host H, Bramwell V, Renard G, Van Glabbeke M, Decoster G (1984) Randomized phase II trial of carminomycin versus 4\u2032-epidoxorubicin in advanced breast cancer. J Clin Oncol 2: 275\u2013281","journal-title":"J Clin Oncol"},{"issue":"Suppl 3","key":"BF6600344_CR33","first-page":"19","volume":"11","author":"SE Sallan","year":"1984","unstructured":"Sallan SE, Clavell LA (1984) Cardiac effects of anthracyclines used in the treatment of childhood acute lymphoblastic leukemia: a 10-year experience. Sem Oncol 11: Suppl 3 19\u201321","journal-title":"Sem Oncol"},{"key":"BF6600344_CR34","first-page":"971","volume":"71","author":"BL Samuels","year":"1987","unstructured":"Samuels BL, Vogelzang NJ, Ruane M, Simon MA (1987) Continuous venous infusion of doxorubicin in advanced sarcomas. Cancer Treat Rep 71: 971\u2013976","journal-title":"Cancer Treat Rep"},{"key":"BF6600344_CR35","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1097\/00001813-200010000-00002","volume":"11","author":"M Schwonzen","year":"2000","unstructured":"Schwonzen M, Kurbacher CM, Mallmann P (2000) Liposomal doxorubicin and weekly paclitaxel in the treatment of metastatic breast cancer. Anticancer Drugs 11: 681\u2013685","journal-title":"Anticancer Drugs"},{"key":"BF6600344_CR36","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1056\/NEJM200103153441101","volume":"344","author":"DJ Slamon","year":"2001","unstructured":"Slamon DJ, Leyland-Jones B, Shak S, Fuchs H, Paton V, Bajamonde A, Fleming T, Eiermann W, Wolter J, Pegram M, Baselga J, Norton L (2001) Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 344: 783\u2013792","journal-title":"N Engl J Med"},{"key":"BF6600344_CR37","first-page":"2","volume":"16","author":"GW Sledge Jr","year":"1997","unstructured":"Sledge Jr GW, Neuberg D, Ingle J, Martino S, Wood W (1997) Phase III trial of doxorubicin (A) vs. doxorubicin + paclitaxel (A+T) as first-line therapy for metastatic breast cancer (MBC): an Intergroup trial. Proc Am Soc Clin Oncol 16: 2","journal-title":"Proc Am Soc Clin Oncol"},{"issue":"Suppl 3","key":"BF6600344_CR38","first-page":"23","volume":"11","author":"DD Von Hoff","year":"1984","unstructured":"Von Hoff DD (1984) Use of daunorubicin in patients with solid tumors. Sem Oncol 11: Suppl 3 23\u201327","journal-title":"Sem Oncol"},{"key":"BF6600344_CR39","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3109\/10717549709052011","volume":"4","author":"ME Wiles","year":"1997","unstructured":"Wiles ME, Bell C, Landfair D, Lyman E, Bendele RA (1997) Anthracycline efficacy in vitro: Cytotoxicity of Liposomal\/Nonliposomal daunorubicin and doxorubicin for multiple tumor cell types. Drug Del 4: 255\u2013262","journal-title":"Drug Del"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6600344.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6600344","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6600344.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:43:06Z","timestamp":1684413786000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6600344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,6,25]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,7]]}},"alternative-id":["BF6600344"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6600344","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,6,25]]}}}